Not everybody responds equally well to these treatments, and its impossible to predict how effective any specific weight loss medication will be for you
Retatrutide Dosing in Phase 2 The Jastreboff phase 2 trial used a 24-week dose-escalation period starting at 2 mg weekly, stepping through 4 mg, 8 mg, and 12 mg, before a 24-week maintenance phase [2]
Recommended Starting Dose of Retatrutide Phase 2 trial protocols typically initiated retatrutide at 2 mg once weekly via subcutaneous injection, allowing gradual physiological adaptation before dose escalation
Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long-acting release
GLP-1 Insight 2 Medicare and commercial insurance plans cover many people who use GLP-1 medications
However, for those wanting to keep their nutrition and medication on track without complexity, WeTide works well